BACKGROUND: Reports from centers treating patients with coronavirus disease 2019 (COVID-19) have noted that such patients frequently develop AKI. However, there have been no direct comparisons of AKI in hospitalized patients with and without COVID-19 that would reveal whether there are aspects of AKI risk, course, and outcomes unique to this infection. METHODS: In a retrospective observational study, we evaluated AKI incidence, risk factors, and outcomes for 3345 adults with COVID-19 and 1265 without COVID-19 who were hospitalized in a large New York City health system and compared them with a historical cohort of 9859 individuals hospitalized a year earlier in the same health system. We also developed a model to identify predictors of stage 2 or 3 AKI in our COVID-19. RESULTS: We found higher AKI incidence among patients with COVID-19 compared with the historical cohort (56.9% versus 25.1%, respectively). Patients with AKI and COVID-19 were more likely than those without COVID-19 to require RRT and were less likely to recover kidney function. Development of AKI was significantly associated with male sex, Black race, and older age (>50 years). Male sex and age >50 years associated with the composite outcome of RRT or mortality, regardless of COVID-19 status. Factors that were predictive of stage 2 or 3 AKI included initial respiratory rate, white blood cell count, neutrophil/lymphocyte ratio, and lactate dehydrogenase level. CONCLUSIONS: Patients hospitalized with COVID-19 had a higher incidence of severe AKI compared with controls. Vital signs at admission and laboratory data may be useful for risk stratification to predict severe AKI. Although male sex, Black race, and older age associated with development of AKI, these associations were not unique to COVID-19.
BACKGROUND: Reports from centers treating patients with coronavirus disease 2019 (COVID-19) have noted that such patients frequently develop AKI. However, there have been no direct comparisons of AKI in hospitalized patients with and without COVID-19 that would reveal whether there are aspects of AKI risk, course, and outcomes unique to this infection. METHODS: In a retrospective observational study, we evaluated AKI incidence, risk factors, and outcomes for 3345 adults with COVID-19 and 1265 without COVID-19 who were hospitalized in a large New York City health system and compared them with a historical cohort of 9859 individuals hospitalized a year earlier in the same health system. We also developed a model to identify predictors of stage 2 or 3 AKI in our COVID-19. RESULTS: We found higher AKI incidence among patients with COVID-19 compared with the historical cohort (56.9% versus 25.1%, respectively). Patients with AKI and COVID-19 were more likely than those without COVID-19 to require RRT and were less likely to recover kidney function. Development of AKI was significantly associated with male sex, Black race, and older age (>50 years). Male sex and age >50 years associated with the composite outcome of RRT or mortality, regardless of COVID-19 status. Factors that were predictive of stage 2 or 3 AKI included initial respiratory rate, white blood cell count, neutrophil/lymphocyte ratio, and lactate dehydrogenase level. CONCLUSIONS:Patients hospitalized with COVID-19 had a higher incidence of severe AKI compared with controls. Vital signs at admission and laboratory data may be useful for risk stratification to predict severe AKI. Although male sex, Black race, and older age associated with development of AKI, these associations were not unique to COVID-19.
Authors: Edward D Siew; T Alp Ikizler; Michael E Matheny; Yaping Shi; Jonathan S Schildcrout; Ioana Danciu; Jamie P Dwyer; Manakan Srichai; Adriana M Hung; James P Smith; Josh F Peterson Journal: Clin J Am Soc Nephrol Date: 2012-03-15 Impact factor: 8.237
Authors: Morgan E Grams; Kunihiro Matsushita; Yingying Sang; Michelle M Estrella; Meredith C Foster; Adrienne Tin; W H Linda Kao; Josef Coresh Journal: J Am Soc Nephrol Date: 2014-04-10 Impact factor: 10.121
Authors: Victor G Puelles; Marc Lütgehetmann; Maja T Lindenmeyer; Jan P Sperhake; Milagros N Wong; Lena Allweiss; Silvia Chilla; Axel Heinemann; Nicola Wanner; Shuya Liu; Fabian Braun; Shun Lu; Susanne Pfefferle; Ann S Schröder; Carolin Edler; Oliver Gross; Markus Glatzel; Dominic Wichmann; Thorsten Wiech; Stefan Kluge; Klaus Pueschel; Martin Aepfelbacher; Tobias B Huber Journal: N Engl J Med Date: 2020-05-13 Impact factor: 91.245
Authors: Mustafa Saad; Ali S Omrani; Kamran Baig; Abdelkarim Bahloul; Fatehi Elzein; Mohammad Abdul Matin; Mohei A A Selim; Mohammed Al Mutairi; Daifullah Al Nakhli; Amal Y Al Aidaroos; Nisreen Al Sherbeeni; Hesham I Al-Khashan; Ziad A Memish; Ali M Albarrak Journal: Int J Infect Dis Date: 2014-10-07 Impact factor: 3.623
Authors: Kwok Hong Chu; Wai Kay Tsang; Colin S Tang; Man Fai Lam; Fernand M Lai; Ka Fai To; Ka Shun Fung; Hon Lok Tang; Wing Wa Yan; Hilda W H Chan; Thomas S T Lai; Kwok Lung Tong; Kar Neng Lai Journal: Kidney Int Date: 2005-02 Impact factor: 10.612
Authors: Matthew D Cheung; Elise N Erman; Shanrun Liu; Nathaniel B Erdmann; Gelare Ghajar-Rahimi; Kyle H Moore; Jeffrey C Edberg; James F George; Anupam Agarwal Journal: Kidney360 Date: 2021-11-05
Authors: Shruti Gupta; Steven G Coca; Lili Chan; Michal L Melamed; Samantha K Brenner; Salim S Hayek; Anne Sutherland; Sonika Puri; Anand Srivastava; Amanda Leonberg-Yoo; Alexandre M Shehata; Jennifer E Flythe; Arash Rashidi; Edward J Schenck; Nitender Goyal; S Susan Hedayati; Rajany Dy; Anip Bansal; Ambarish Athavale; H Bryant Nguyen; Anitha Vijayan; David M Charytan; Carl E Schulze; Min J Joo; Allon N Friedman; Jingjing Zhang; Marie Anne Sosa; Eric Judd; Juan Carlos Q Velez; Mary Mallappallil; Roberta E Redfern; Amar D Bansal; Javier A Neyra; Kathleen D Liu; Amanda D Renaghan; Marta Christov; Miklos Z Molnar; Shreyak Sharma; Omer Kamal; Jeffery Owusu Boateng; Samuel A P Short; Andrew J Admon; Meghan E Sise; Wei Wang; Chirag R Parikh; David E Leaf Journal: J Am Soc Nephrol Date: 2020-10-16 Impact factor: 10.121
Authors: Luise Hassler; Fabiola Reyes; Matthew A Sparks; Paul Welling; Daniel Batlle Journal: Clin J Am Soc Nephrol Date: 2021-06-14 Impact factor: 8.237
Authors: Matthias Diebold; Tobias Zimmermann; Michael Dickenmann; Stefan Schaub; Stefano Bassetti; Sarah Tschudin-Sutter; Roland Bingisser; Corin Heim; Martin Siegemund; Stefan Osswald; Gabriela M Kuster; Katharina M Rentsch; Tobias Breidthardt; Raphael Twerenbold Journal: J Clin Med Date: 2021-05-25 Impact factor: 4.241
Authors: Danilo Candido de Almeida; Maria do Carmo Pinho Franco; Davi Rettori Pardo Dos Santos; Marina Colella Santos; Isabela Soucin Maltoni; Felipe Mascotte; Alexandra Aparecida de Souza; Paula Massaroni Pietrobom; Eduardo Alexandrino Medeiros; Paulo Roberto Abrão Ferreira; Flavia Ribeiro Machado; Miguel Angelo Goes Journal: PLoS One Date: 2021-05-25 Impact factor: 3.240
Authors: Rodrigo Bezerra; Flávio Teles; Polyana Bezerra Mendonca; Tedla Damte; Andrew Likaka; Edyniesky Ferrer-Miranda; Jones Oliveira de Albuquerque; José Luiz de Lima Filho Journal: Ren Fail Date: 2021-12 Impact factor: 2.606